Prognostic Value of Minimal Residual Disease Quantification by Real-Time Reverse Transcriptase Polymerase Chain Reaction in Patients With Core Binding Factor Leukemias

Abstract

MRD quantification by real-time RT-PCR allows the identification of patients with a high risk of relapse among the CBF leukemias.